SINUVA® Mometasone Furoate 1350 mcg Implant for Nasal Polyps

Name: SINUVA® Mometasone Furoate 1350 mcg Implant for Nasal Polyps
Brand: Intersect ENT Inc
SKU: USAMP#54988164

USAMP#54988164SKU: 10599000301SINUVA®

License Required

Product Spotlight

SINUVA® Mometasone Furoate 1350 mcg Implant is a clinically proven, steroid-releasing implant designed specifically for adults over 18 who have undergone ethmoid sinus surgery and are suffering from recurrent nasal polyps.
This innovative treatment option provides targeted, localized delivery of mometasone furoate directly to the sinus tissue, helping to reduce polyp size and alleviate associated nasal congestion and obstruction.
Manufactured by Intersect ENT Inc, SINUVA® is a minimally invasive option that offers an alternative to systemic steroids or repeat surgical procedures for patients with challenging nasal polyp conditions.

SINUVA® Mometasone Furoate 1350 mcg Implant is a clinically proven, steroid-releasing implant designed specifically for adults over 18 who have undergone ethmoid sinus surgery and are suffering from recurrent nasal polyps.
This innovative treatment option provides targeted, localized delivery of mometasone furoate directly to the sinus tissue, helping to reduce polyp size and alleviate associated nasal congestion and obstruction.
Manufactured by Intersect ENT Inc, SINUVA® is a minimally invasive option that offers an alternative to systemic steroids or repeat surgical procedures for patients with challenging nasal polyp conditions.